EspaƱol
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 40 for your search:
Drug:  thalidomide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TaCyDexVMP7, NCT00652041

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT: 2005-001628-35, EBMT-CLWP: 42206611, NCT00256776

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000530050, P30CA015083, MC0289, 421-03, MAYO-MC0289, MAYO-IRB-421-03, NCT00432458

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C05009, NCT00507416

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 55 and over
Sponsor: Other
Protocol IDs: TMSG-2005-001, NCT00934154

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03150, CDR0000404161, E4A03, U10CA021115, U10CA180820, ECOG-E4A03, NCT00098475

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0179, NCI-2009-01622, NCT00966693

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MC0982, NCI-2009-01699, PT-171-502, 09-004091, NCT01057225

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: PRO-00001215, NCT01242267

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 3 to 21
Sponsor: Other
Protocol IDs: CNS 1099, NCT00179881

11.

Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 30
Sponsor: Other
Protocol IDs: CCLG-LT-2005-05, CCLG-SIOPEL-HCC, CCLG-SIOPEL-5, EU-20590, EUDRACT-2005-000427-42, NCT00276705

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0507, CDR0000455000, P30CA006973, JHOC-J0507, JHOC-05041402, J0507, NCT00276744

13.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: Other
Protocol IDs: SQMM01(dtZ), NCT00263484

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Thalidomide-MALT, Eudract number 2005-000008-14, NCT00373646

15.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: DM02-595, NCT00412542

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000530973, P30CA015083, MC028A, 1360-03, MAYO-MC028A, MAYO-IRB-1360-03, NCT00445900

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000563183, RPCI-I-59105, I 59105, NCT00523848

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 940813, TTY-TU0510, NCT00519688

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: 26866138-MMY-2043, NCT00531453

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: 25009, 7R01CA115399, NCT00670631

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: 06143, P30CA033572, CHNMC-06143, MILLENNIUM-06143, CDR0000624513, NCT00792142

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Over 18
Sponsor: Other
Protocol IDs: CRUK-UCL-AITL, AITL, CRUK-UCL-AITL, EUDRACT-2005-003931-40, EU-20947, NCT00958854

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11212, UVACC-HIC-11212, UVACC-LUNG3, UVACC-29403, NCT00114192

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 64
Sponsor: Other
Protocol IDs: 20030165, SCCC-2003027, WIRB-20051242, EPROST-20030165, SCCC-20051242, SCCC-20030165, NCT00450801

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: S0204, U10CA032102, SWOG-S0204, NCT00040937
1   
New Search